The studies were conducted with a formulation based on HemCon’s newest proprietary platform technology that provides a controlled release broad spectrum antifungal and antibacterial agent to fight infection.
Upon issuance, the patent will broadly cover methods of treating obesity with combinations of bupropion and naltrexone, the two active agents in Contrave. It is a companion to
The three inventions Neuralstem has licensed from Cleveland Clinic are: a stabilized platform and microelectrode recording guidance validation, a floating cannula for spinal cord therapeutic injection, and a
Dr Dionne was previously CEO of Alantos Pharmaceuticals, where he led the company through the acquisition by Amgen for more than $300 million in cash. Prior to Alantos,
The agreement between Avidas and Crown includes development collaboration and additional dermatology products. Financial terms of the transaction were not disclosed. The first products to be launched by
REG1 is a two-component system composed of an aptamer-based anticoagulant, RB006, and its matched, active reversal agent, RB007, which specifically binds to and neutralizes RB006. The Phase IIa
The study was initiated in July 2008 in bronchiectasis centers in the UK and enrolled a total of 36 patients as planned. The subjects were randomized to two
According to Dr Reddy’s Laboratories, EpiCeram emulsion provides an optimal 3:1:1 ratio of ceramides, free fatty acids and cholesterol to help repair the damaged skin barrier in order
In the study, six end-stage renal disease (ESRD) patients received a series of three, four-hour Hemopurifier treatments every other day during the course of one week. The treatment
Omrix said that the European Medicines Agency’s (EMEA’s) approval permits Evicel to be marketed in Europe under the following indication: “As a supportive treatment in surgery where standard
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.